{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:40Z","timestamp":1790675380793,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"DA-R3708863"},{"name":"Furiex"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bcp.2014.09.015","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T18:55:15Z","timestamp":1411930515000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers"],"prefix":"10.1016","volume":"92","author":[{"given":"Wakako","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivone","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard S.","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prohaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi A.","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.09.015_bib0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pgmj.2003.015511","article-title":"Analgesia for patients with advanced disease: I","volume":"80","author":"Hall","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bcp.2014.09.015_bib0010","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-5347(25)00271-X","article-title":"Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse","volume":"241","author":"Porreca","year":"1987","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.bcp.2014.09.015_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainresbull.2012.09.006","article-title":"Spinal interaction between the highly selective mu agonist DAMGO and several delta opioid receptor ligands in naive and morphine-tolerant mice","volume":"90","author":"Szentirmay","year":"2013","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bcp.2014.09.015_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)31528-4","article-title":"Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence","volume":"208","author":"Vaught","year":"1979","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.bcp.2014.09.015_bib0030","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(25)31828-8","article-title":"A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphine-induced analgesia","volume":"211","author":"Vaught","year":"1979","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.bcp.2014.09.015_bib0035","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1073\/pnas.0307601101","article-title":"A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia","volume":"101","author":"Gomes","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.09.015_bib0040","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","article-title":"Heterodimerization of mu and delta opioid receptors: a role in opiate synergy","volume":"20","author":"Gomes","year":"2000","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.bcp.2014.09.015_bib0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1124\/mol.110.070847","article-title":"G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding","volume":"79","author":"Gomes","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0050","doi-asserted-by":"crossref","first-page":"ra54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers after chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.bcp.2014.09.015_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2014.09.015_bib0060","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj080114","article-title":"Opioid ligands with mixed mu\/delta opioid receptor interactions: an emerging approach to novel analgesics","volume":"8","author":"Ananthan","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.bcp.2014.09.015_bib0065","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1021\/jm300686p","article-title":"14-Alkoxy- and 14-acyloxypyridomorphinans: mu agonist\/delta antagonist opioid analgesics with diminished tolerance and dependence side effects","volume":"55","author":"Ananthan","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.09.015_bib0070","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1016\/j.bmcl.2012.05.042","article-title":"Identification of a dual delta OR antagonist\/mu OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)","volume":"22","author":"Breslin","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.015_bib0075","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1073\/pnas.0506627102","article-title":"Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","volume":"102","author":"Daniels","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.09.015_bib0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed micro opioid receptor agonist\/micro opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0085","doi-asserted-by":"crossref","DOI":"10.1021\/cb400113d","article-title":"An immunocytochemical-derived correlate for evaluating the bridging of heteromeric mu-delta opioid protomers by bivalent ligands","author":"Yekkirala","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0090","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3748\/wjg.v18.i12.1391","article-title":"Opiate-induced constipation related to activation of small intestine opioid mu2-receptors","volume":"18","author":"Chen","year":"2012","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.bcp.2014.09.015_bib0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01296258","article-title":"Role of loperamide and placebo in management of irritable bowel syndrome (IBS)","volume":"29","author":"Cann","year":"1984","journal-title":"Digest Dis Sci"},{"key":"10.1016\/j.bcp.2014.09.015_bib0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2125.2003.01966.x","article-title":"Evaluation of drug treatment in irritable bowel syndrome","volume":"56","author":"Talley","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365528709091004","article-title":"Loperamide treatment of the irritable bowel syndrome","volume":"130","author":"Hovdenak","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.bcp.2014.09.015_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1708-8305.1995.tb00613.x","article-title":"Observational study of travelers\u2019 diarrhea","volume":"2","author":"Meuris","year":"1995","journal-title":"J Travel Med"},{"key":"10.1016\/j.bcp.2014.09.015_bib0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.gastro.2013.04.006","article-title":"Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study","volume":"145","author":"Dove","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2014.09.015_bib0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1476-5381.1964.tb02040.x","article-title":"Stimulant actions of volatile anaesthetics on smooth muscle","volume":"22","author":"Rang","year":"1964","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.bcp.2014.09.015_bib0125","first-page":"157","article-title":"Opioid receptor oligomerization. Detection and functional characterization of interacting receptors","volume":"84","author":"Gomes","year":"2003","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.bcp.2014.09.015_bib0130","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.1222044110","article-title":"Identification of a mu-delta opioid receptor heteromer-biased agonist with antinociceptive activity","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.09.015_bib0135","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R-CB(1)R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Rozenfeld","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2014.09.015_bib0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.peptides.2009.11.005","article-title":"NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice","volume":"31","author":"Moriya","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2014.09.015_bib0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(95)00658-3","article-title":"K+ channel openers delay intestinal transit and have antidiarrheal activity","volume":"287","author":"Poggioli","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0150","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1074\/jbc.M609254200","article-title":"Conformation state-sensitive antibodies to G-protein-coupled receptors","volume":"282","author":"Gupta","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.015_bib0155","series-title":"G protein-coupled receptor signaling","author":"Gomes","year":"2013"},{"key":"10.1016\/j.bcp.2014.09.015_bib0160","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2011.05.042","article-title":"Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice","volume":"141","author":"Poole","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2014.09.015_bib0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bjp.0701130","article-title":"Role of tachykinins in castor oil diarrhoea in rats","volume":"121","author":"Croci","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(87)90510-3","article-title":"Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors","volume":"144","author":"Marcais-Collado","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0175","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12798","article-title":"Revolution in GPCR signaling: opioid receptor heteromers as novel therapeutic targets","author":"Fujita","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0180","article-title":"Mu-Delta opioid receptor heteromers: new pharmacology and novel therapeutic possibilities","author":"Fujita","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0185","first-page":"2455","article-title":"Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers","volume":"21","author":"Rozenfeld","year":"2007","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0190","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0022-3565(24)36506-1","article-title":"Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors","volume":"280","author":"Sanchez-Blazquez","year":"1997","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.bcp.2014.09.015_bib0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(00)80836-3","article-title":"Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice","volume":"24","author":"Zhu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2014.09.015_bib0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/ml300083p","article-title":"Tuned-affinity bivalent ligands for the characterization of opioid receptor heteromers","volume":"3","author":"Harvey","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.015_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2007.02.040","article-title":"Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores","volume":"566","author":"Lenard","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0210","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1021\/jm980724+","article-title":"The opioid mu agonist\/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats","volume":"42","author":"Schiller","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.09.015_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI107539","article-title":"Inhibition of ileal water absorption by intraluminal fatty acids. Influence of chain length, hydroxylation, and conjugation of fatty acids","volume":"53","author":"Ammon","year":"1974","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bcp.2014.09.015_bib0220","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1172\/JCI107569","article-title":"Effects of oleic and ricinoleic acids on net jejunal water and electrolyte movement. Perfusion studies in man","volume":"53","author":"Ammon","year":"1974","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bcp.2014.09.015_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0016-5085(73)80094-0","article-title":"Stimulation of colonic secretion of water and electrolytes by hydroxy fatty acids","volume":"64","author":"Bright-Asare","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2014.09.015_bib0230","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1073\/pnas.1201627109","article-title":"Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors","volume":"109","author":"Tunaru","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.09.015_bib0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0091-3057(97)00457-7","article-title":"Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior","volume":"59","author":"Angrini","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2014.09.015_bib0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0031-9384(95)00137-8","article-title":"Effects of novelty and conditioned fear on small intestinal and colonic motility and behaviour in the rat","volume":"58","author":"Stam","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bcp.2014.09.015_bib0245","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0166-4328(97)00046-6","article-title":"Behavioural and intestinal responses to novelty in rats selected for diverging reactivity in the open field test","volume":"88","author":"Stam","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2014.09.015_bib0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.FP0050353","article-title":"Novelty stress increases fecal pellet output in Mongolian gerbils: effects of several drugs","volume":"98","author":"Okano","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.09.015_bib0255","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.lfs.2005.07.048","article-title":"Comparison of opioid receptor distributions in the rat ileum","volume":"78","author":"Gray","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2014.09.015_bib0260","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.09.015_bib0265","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.bcp.2014.09.015_bib0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.coph.2006.06.007","article-title":"Opioid receptor signaling: relevance for gastrointestinal therapy","volume":"6","author":"Bohn","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.015_bib0275","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2009.0015","article-title":"Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management","volume":"5","author":"Holzer","year":"2009","journal-title":"J Opioid Manage"},{"key":"10.1016\/j.bcp.2014.09.015_bib0280","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1186\/ar1782","article-title":"Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2014.09.015_bib0295","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","article-title":"Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain","volume":"22","author":"Tuteja","year":"2010","journal-title":"Neurogastroenterol Motility Off J Eur Gastrointestinal Motility Soc"},{"key":"10.1016\/j.bcp.2014.09.015_bib0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.108.143438","article-title":"Morphine tolerance in the mouse ileum and colon","volume":"327","author":"Ross","year":"2008","journal-title":"J Pharmacol Exp Therap"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214005590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214005590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T22:02:13Z","timestamp":1746396133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214005590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0006295214005590"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.09.015","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}